Researcher
Veronique Daniëls
- Disciplines:Neurological and neuromuscular diseases
Affiliations
- Research Group for Neurobiology and Gene Therapy (Division)
Member
From1 Oct 2006 → Today
Projects
1 - 5 of 5
- Targeting ATP13A3 for neuroblastoma therapyFrom1 Mar 2023 → TodayFunding: IOF - technology validation in lab
- Development and in vivo validation of a kit for polyamine transport tracking and quantificationFrom1 Oct 2020 → 30 Sep 2022Funding: IOF - technology validation in lab
- Drug discovery for Parkinson’s disease using a translational screening platformFrom1 Oct 2020 → TodayFunding: IOF - technology validation in lab
- SyNEURgyFrom1 Sep 2018 → 31 Aug 2020Funding: BOF - Bilateral scientific cooperation
- Drug discovery and gene therapyFrom26 Jun 2017 → TodayFunding: IOF - mandates, IOF - Industrial Research Fund
Publications
1 - 9 of 9
- New Ferritin-Based Tissue-Specific Genetic Vectors for MR Visualization of Neurogenesis(2020)
Authors: Anna Pishchelko, Anna Naumova, Veronique Daniëls, Irina Thiry, Mikhail Svetlik, Nikolay Nemirovich-Danchenko, Yana Tyumentseva, Marina Khodanovich
Pages: S246 - S246 - Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor(2020)
Authors: Veronique Daniëls
Pages: 1 - 10 - Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses(2015)
Authors: Veronique Daniëls
Pages: 398 - 409 - Modulation of the conformational state of the SV2A protein by an allosteric mechanism as evidenced by ligand binding assays(2013)
Authors: Veronique Daniëls
Pages: 1091 - 1101 - On the road to leucine-rich repeat kinase 2 signalling: evidence from cellular and in vivo studies(2011)
Authors: Veronique Daniëls, Veerle Baekelandt, Jean-Marc Taymans
Pages: 1 - 15 - Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant(2011)
Authors: Veronique Daniëls, Renée Vancraenenbroeck, Evy Lobbestael, Marc De Maeyer, Veerle Baekelandt, Jean-Marc Taymans
Pages: 304 - 315 - Biochemical and cell biological study of leucine-rich repeat kinase 2 (LRRK2), a kinase linked to Parkinson's disease(2010)
Authors: Veronique Daniëls, Veerle Baekelandt, Jean-Marc Taymans
- Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology(2010)
Authors: Angélique Deleersnijder, Veronique Daniëls, Sarah Schreurs, Sebastian Munck, Veerle Reumers, Hans Pottel, Yves Engelborghs, Chris Van den Haute, Jean-Marc Taymans, Zeger Debyser, et al.
Pages: 2454 - 2463 - The Parkinson disease-associated Leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation(2008)
Authors: Jean-Marc Taymans, Veronique Daniëls, Veerle Baekelandt
Pages: 16906 - 16914